Ronald Bailey | September 1, 2009
The genome sequencing company
Illumina has just delivered the results of a complete human genome
sequencing to a customer. InSequence
reports:
The company said that it generated more than 110 gigabases of data, sequencing the genome to more than 30-fold coverage, at its CLIA-certified laboratory, which is also accredited by the College of American Pathologists, using its Genome Analyzer technology.
Illumina delivered the genome to the customer — Hermann Hauser, a partner of Amadeus Capital Partners, and an investor in Solexa, which Illumina acquired in early 2007 — on Aug. 20. in the presence of Hauser's physician, Michael Nova, chief medical officer of San Diego-based direct-to-consumer DNA testing company Pathway Genomics. The analysis revealed 300,000 novel SNPs in Hauser's genome, according to Illumina.
The company launched its $48,000 personal genome sequencing service, which it offers through physicians, in June.
I just got back this afternoon from a National Academy of Sciences workshop on direct-to-consumer gene testing. One participant confidently predicted that the first $1,000 whole genome scan will become available in the next two years.
Reason needs your support. Please donate today!
Try Reason's award-winning print edition today! Your first issue is FREE if you are not completely satisfied.
(310) 367-6109
3415 S. Sepulveda Blvd.
Suite 400
Los Angeles, CA 90034
(310) 391-2245
Editor's Note: We invite comments and request that they be civil and on-topic. We do not moderate or assume any responsibility for comments, which are owned by the readers who post them. Comments do not represent the views of Reason.com or Reason Foundation. We reserve the right to delete any comment or disable your ability to comment for any reason at any time.
Russ 2000|9.1.09 @ 4:18PM|#
WTF is a "gigabase"?
|9.1.09 @ 4:22PM|#
One participant confidently predicted that the first $1,000 whole genome scan will become available in the next two years.
I'm working with a genetics startup that will provide whole genome analysis, and we are counting on this price decrease for our business model.
|9.1.09 @ 4:28PM|#
a Gigabase is 1 billion base pairs of DNA (C-T-G-A)
|9.1.09 @ 4:30PM|#
Ron: Who is the confident participant who predicted the $1K genome within two years?
Russ 2000|9.1.09 @ 5:01PM|#
Kant etc., thanks.
Gunboat Diplomacy|9.1.09 @ 5:36PM|#
"The company launched its $48,000 personal genome sequencing service, which it offers through physicians, in June."
$48K? But personal genome sequencing services are a RIGHT! Goddam greedy doctors.
|9.1.09 @ 6:39PM|#
MD: Actually several basically accepted the proposition, but the guy who specifically said it was British molecular geneticist Timothy Aitman.
wayne|9.1.09 @ 7:49PM|#
Wow, at $1000 I might buy it. The difficulty I see in it for a customer is interpretation, e.g. say you are interested in using your genome to shed light on your genealogy, how do you use the info to do that?
|9.1.09 @ 7:54PM|#
$1000 in two years is too optimistic, but half price every two years much like Moore's law is totally possible: $24K in two years, $12K in 4, $6K in 6, $3K in 8 an $1500 in 10 years.
|9.1.09 @ 10:25PM|#
David N: You may be way too pessimistic. Gene scanning is dropping in price much faster than Moore's Law. This quote from a Forbes June 2007 article:
Small biotechs are starting to produce ultrafast gene machines that aim to unravel all 3 billion DNA letters that contain the human blueprint for $100,000. It would be a thirtyfold cost reduction in seven years. "That beats Moore's Law hands down," says Eric Lander, head of the Broad Institute of MIT and Harvard, funded by billionaire Eli Broad. "It's a wonderfully disruptive technology."